Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Oncology Biosimilars
Cancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry of biosimilars into the market. Biosimilars are being incorporated into oncology treatment practices in the supportive care setting. Biosimilars are synthesized with the use of biologic components such as monoclonal antibodies, proteins, hormones, nucleic acids, colony stimulating factors, interleukins, and enzymes.
Technavio’s analysts forecast the global oncology biosimilars market to grow at a CAGR of 31.76% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global oncology biosimilars market for the period 2016-2020. To calculate the market size, the report considers revenue generated from the sales of biosimilars used to treat cancer.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Oncology Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Biocon
• Celltrion
• Dr. Reddy's Laboratories
• F. Hoffmann-La Roche
• Hospira
• Mylan
• Sandoz
Other prominent vendors
• AbbVie
• Allergan
• Amgen
• AstraZeneca
• Baxter
• Biogen
• BioXpress Therapeutics
• Boehringer Ingelheim
• Cipla
• Coherus BioSciences
• Coherus BioSciences
• Daiichi Sankyo
• Emcure Pharmaceuticals
• GlaxoSmithKline (GSK)
• Intas Pharmaceuticals
• Merck
• Pfizer
• Sanofi
• 3SBio
• Wockhardt
Market driver
• Rise in number of patent expiries
• For a full, detailed list, view our report
Market challenge
• Risks related to failure of drugs in the market
• For a full, detailed list, view our report
Market trend
• Emergence of biosimilars
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Cancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry of biosimilars into the market. Biosimilars are being incorporated into oncology treatment practices in the supportive care setting. Biosimilars are synthesized with the use of biologic components such as monoclonal antibodies, proteins, hormones, nucleic acids, colony stimulating factors, interleukins, and enzymes.
Technavio’s analysts forecast the global oncology biosimilars market to grow at a CAGR of 31.76% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global oncology biosimilars market for the period 2016-2020. To calculate the market size, the report considers revenue generated from the sales of biosimilars used to treat cancer.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Oncology Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Biocon
• Celltrion
• Dr. Reddy's Laboratories
• F. Hoffmann-La Roche
• Hospira
• Mylan
• Sandoz
Other prominent vendors
• AbbVie
• Allergan
• Amgen
• AstraZeneca
• Baxter
• Biogen
• BioXpress Therapeutics
• Boehringer Ingelheim
• Cipla
• Coherus BioSciences
• Coherus BioSciences
• Daiichi Sankyo
• Emcure Pharmaceuticals
• GlaxoSmithKline (GSK)
• Intas Pharmaceuticals
• Merck
• Pfizer
• Sanofi
• 3SBio
• Wockhardt
Market driver
• Rise in number of patent expiries
• For a full, detailed list, view our report
Market challenge
• Risks related to failure of drugs in the market
• For a full, detailed list, view our report
Market trend
• Emergence of biosimilars
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
